{"entity":{"type":"insider","cik":"0001725018","url":"/insider/0001725018","json_url":"/insider/0001725018.json","name":"Nazzi Gianfranco","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":14,"first":"2018-03-14","last":"2021-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Nazzi Gianfranco","source":"filing","n_filings":14,"first_seen":"2018-03-14","last_seen":"2021-03-08"}],"transactions":[{"id":4475861,"accession":"0001209191-21-018524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018524","line_url":"/filing/0001209191-21-018524#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12935.0,"shares_display":"12,935","price_per_share":10.5844,"price_display":"10.58","price_state":"stated","total_value":136909.214,"total_display":"136,909.21","total_whole":"136,909","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":4475733,"accession":"0001209191-21-017761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017761","line_url":"/filing/0001209191-21-017761#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":10.8796,"price_display":"10.88","price_state":"stated","total_value":15231.44,"total_display":"15,231.44","total_whole":"15,231","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"},{"id":4177796,"accession":"0001209191-21-015847","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-015847","line_url":"/filing/0001209191-21-015847","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75587.357,"shares_display":"75,587.36","price_per_share":10.873837397399674,"price_display":"10.87","price_state":"stated","total_value":821924.6293172,"total_display":"821,924.63","total_whole":"821,925","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider","n_lines":2},{"id":5373979,"accession":"0001209191-21-009637","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009637","line_url":"/filing/0001209191-21-009637","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21635.0,"shares_display":"21,635","price_per_share":12.7209,"price_display":"12.72","price_state":"stated","total_value":275216.6715,"total_display":"275,216.67","total_whole":"275,217","shares_owned_after":60410.357,"shares_owned_after_display":"60,410.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":2368726,"accession":"0001209191-20-020164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020164","line_url":"/filing/0001209191-20-020164#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":7.1714,"price_display":"7.17","price_state":"stated","total_value":2474.133,"total_display":"2,474.13","total_whole":"2,474","shares_owned_after":19844.357,"shares_owned_after_display":"19,844.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":3087855,"accession":"0001209191-20-016460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016460","line_url":"/filing/0001209191-20-016460#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":548.0,"shares_display":"548","price_per_share":11.7657,"price_display":"11.77","price_state":"stated","total_value":6447.6036,"total_display":"6,447.60","total_whole":"6,448","shares_owned_after":19315.357,"shares_owned_after_display":"19,315.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":3234135,"accession":"0001209191-20-008165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008165","line_url":"/filing/0001209191-20-008165#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":12.2417,"price_display":"12.24","price_state":"stated","total_value":50864.2635,"total_display":"50,864.26","total_whole":"50,864","shares_owned_after":18464.357,"shares_owned_after_display":"18,464.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8299323,"accession":"0001209191-19-050265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050265","line_url":"/filing/0001209191-19-050265#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":962.0,"shares_display":"962","price_per_share":7.8203,"price_display":"7.82","price_state":"stated","total_value":7523.1286,"total_display":"7,523.13","total_whole":"7,523","shares_owned_after":10678.357,"shares_owned_after_display":"10,678.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":7876089,"accession":"0001209191-19-020162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020162","line_url":"/filing/0001209191-19-020162#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":16.6446,"price_display":"16.64","price_state":"stated","total_value":5326.272,"total_display":"5,326.27","total_whole":"5,326","shares_owned_after":9002.357,"shares_owned_after_display":"9,002.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8597899,"accession":"0001209191-19-019330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019330","line_url":"/filing/0001209191-19-019330#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":15.6898,"price_display":"15.69","price_state":"stated","total_value":5099.185,"total_display":"5,099.18","total_whole":"5,099","shares_owned_after":8450.357,"shares_owned_after_display":"8,450.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8451442,"accession":"0001209191-19-016097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016097","line_url":"/filing/0001209191-19-016097#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":512.0,"shares_display":"512","price_per_share":16.8844,"price_display":"16.88","price_state":"stated","total_value":8644.8128,"total_display":"8,644.81","total_whole":"8,645","shares_owned_after":7892.357,"shares_owned_after_display":"7,892.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":6396966,"accession":"0001209191-18-051778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051778","line_url":"/filing/0001209191-18-051778#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1379.0,"shares_display":"1,379","price_per_share":23.691,"price_display":"23.69","price_state":"stated","total_value":32669.889,"total_display":"32,669.89","total_whole":"32,670","shares_owned_after":7005.357,"shares_owned_after_display":"7,005.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6701891,"accession":"0001209191-18-020862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020862","line_url":"/filing/0001209191-18-020862#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457.0,"shares_display":"457","price_per_share":17.892,"price_display":"17.89","price_state":"stated","total_value":8176.644,"total_display":"8,176.64","total_whole":"8,177","shares_owned_after":5746.357,"shares_owned_after_display":"5,746.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6331977,"accession":"0001209191-18-019565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019565","line_url":"/filing/0001209191-18-019565#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001725018","owner_name":"Nazzi Gianfranco","owner_display_name":"Nazzi Gianfranco","owner_url":"/insider/0001725018","role":"Officer (EVP, Growth Markets Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Growth Markets Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Growth Markets Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":19.498,"price_display":"19.50","price_state":"stated","total_value":8988.578,"total_display":"8,988.58","total_whole":"8,989","shares_owned_after":5331.357,"shares_owned_after_display":"5,331.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, International Markets)","n_filings":14,"first_seen":"2018-03-14","last_seen":"2021-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001725018","retrieved_at":"2026-08-24T23:15:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}